| 摘要 |
The present invention relates to a pharmaceutical composition or a supplement product for use in the treatment of metabolic disorders deriving from or connected to an insulin resistance syndrome, diabetes, polycystic ovary syndrome, steatosis, cirrhosis, hyperlipidaemia, atherosclerosis and obesity. |
